tiprankstipranks
Trending News
More News >
Nanoveu Ltd. (AU:NVU)
ASX:NVU
Australian Market

Nanoveu Ltd. (NVU) AI Stock Analysis

Compare
26 Followers

Top Page

AU:NVU

Nanoveu Ltd.

(Sydney:NVU)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
AU$0.08
▼(-12.22% Downside)
The score is primarily constrained by weak financial performance, led by a severe revenue contraction, widening losses, and persistent negative free cash flow. Technicals are comparatively supportive with the price above key moving averages and positive MACD, but mixed momentum limits the uplift. Valuation impact is neutral because P/E and dividend yield were not provided.
Positive Factors
Product focus / niche technology
The company’s core offering—nanotechnology films and coatings for electronic displays—is a durable, specialized product niche. That focus supports differentiated IP and product-led revenue opportunities with long-term demand from device manufacturers and surface-protection markets.
Improved leverage / balance-sheet stabilization
Debt-to-equity improvement to ~0.34 from prior negative equity signals reduced solvency stress. A more stable capital structure enhances runway for restructuring or commercialization efforts, lowering immediate bankruptcy risk and improving ability to access funding if operational recovery takes hold.
Strong product-level gross margins
Elevated gross margin in 2024 suggests attractive unit economics for the company’s films/coatings. If revenue scale is restored and fixed overheads are reined in, these product-level margins could underpin sustainable profitability over a multi-quarter horizon.
Negative Factors
Severe revenue collapse
A roughly 91% revenue decline is structurally damaging: it erodes customer relationships, reduces operating leverage, and undermines the ability to convert product economics into sustainable profits. Recovery will require regaining lost sales or new revenue streams.
Persistent negative cash generation
Consistent annual cash burn and a 21% drop in FCF in 2024 mean the business cannot self-fund growth or cover losses. This structural weakness forces reliance on external financing, increasing dilution or refinancing risk and constraining strategic investments.
Widening losses and weak returns
Expanding net losses and negative operating earnings degrade equity value and reduce reinvestment capacity. Persistent unprofitability pressures ROE and heightens the risk of further balance-sheet deterioration absent clear, sustained operating improvements.

Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)

Nanoveu Ltd. Business Overview & Revenue Model

Company DescriptionNanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone screen covers and cases, as well as a commercial film for various surface applications. It also offers EyeFly3D that converts 2D digital displays into 3D without the need for 3D glasses. In addition, the company is developing Customskins vending machines for precisely applying screen covers to mobile phones in just over a minute; EyeFyx, a vision correction solution using hardware and software to manipulate screen output; and anti-flamatory coating technology used in plastic laminates for the aviation and transport sectors. The company was incorporated in 2018 and is based in Subiaco, Australia.
How the Company Makes MoneyNanoveu Ltd. generates revenue through the sale of its proprietary products and solutions. The company monetizes its technology by selling Nanoshield screen protectors directly to consumers as well as through distribution partnerships with retailers and device manufacturers. Additionally, the EyeFly3D product line is sold to consumers looking for enhanced visual experiences on their mobile devices. Revenue is further supported by licensing agreements and collaborations with technology partners looking to integrate Nanoveu's nanotechnology into their own products. Significant partnerships with manufacturers and retailers enhance the company's market reach and contribute to its earnings.

Nanoveu Ltd. Financial Statement Overview

Summary
Income statement and cash flow are very weak: revenue fell ~91% in 2024 vs 2023, losses widened materially, and operating/free cash flow are negative every year with further FCF deterioration in 2024. Balance sheet leverage looks more moderate in 2024 (debt-to-equity ~0.34) versus the prior negative-equity period, but ongoing losses keep financial risk elevated.
Income Statement
12
Very Negative
Revenue has deteriorated sharply, culminating in a ~91% drop in 2024 versus 2023. Profitability is consistently weak: the company remains deeply loss-making every year shown, with negative operating earnings and net losses that expanded materially in 2024. While gross profit margin appears unusually high in 2024, it is not translating into operating leverage given the very large expense base relative to the current revenue run-rate.
Balance Sheet
38
Negative
Leverage looks moderate in 2024 (debt-to-equity ~0.34), a clear improvement versus prior years when equity was negative (2022–2023), which typically signals balance-sheet stress. However, overall returns remain poor (negative return on equity in 2024) and the recent history of negative equity highlights potential fragility if losses persist. Total assets increased meaningfully in 2024, but the balance sheet still depends on a turnaround in operating performance to stabilize.
Cash Flow
18
Very Negative
Cash generation is a key weakness: operating cash flow and free cash flow are negative in every year shown, indicating ongoing cash burn. Free cash flow declined further in 2024 (down ~21%), reinforcing the lack of self-funding capacity. Cash flow is broadly consistent with reported losses (free cash flow roughly tracking net income), which suggests limited non-cash add-backs to cushion the burn.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue276.96K6.87K102.54K159.51K781.21K367.86K
Gross Profit172.49K10.53K25.27K72.37K386.56K127.70K
EBITDA-3.90M-2.73M-1.98M-2.45M-1.97M-1.67M
Net Income-4.87M-2.85M-2.16M-2.67M-2.32M-1.76M
Balance Sheet
Total Assets13.81M1.32M513.00K427.33K2.75M1.79M
Cash, Cash Equivalents and Short-Term Investments2.08M498.30K73.07K248.14K2.01M1.15M
Total Debt210.51K126.33K225.26K300.00K986.68K333.78K
Total Liabilities851.46K983.58K622.40K700.75K1.17M579.78K
Stockholders Equity13.07M374.94K-109.41K-273.41K1.58M1.21M
Cash Flow
Free Cash Flow-3.17M-2.10M-2.01M-2.82M-2.04M-2.27M
Operating Cash Flow-3.17M-2.10M-2.01M-2.82M-2.04M-2.25M
Investing Cash Flow-399.83K-258.66K0.000.000.00-20.91K
Financing Cash Flow6.14M2.53M1.83M142.12K2.91M1.22M

Nanoveu Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.09
Negative
100DMA
0.09
Negative
200DMA
0.07
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
35.67
Neutral
STOCH
-8.27
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NVU, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and above the 200-day MA of 0.07, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 35.67 is Neutral, neither overbought nor oversold. The STOCH value of -8.27 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NVU.

Nanoveu Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
49
Neutral
AU$85.36M
48
Neutral
AU$30.75M-102.50-3.14%2.98%93.55%
48
Neutral
AU$26.12M-3.97-31.01%-3.43%-40.65%
43
Neutral
AU$29.71M-13.507.32%67.11%
38
Underperform
AU$23.40M-5.00-135.50%-48.98%-12.82%
37
Underperform
AU$809.46K-0.17
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NVU
Nanoveu Ltd.
0.08
0.03
71.74%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:VIG
Victor Group Holdings Ltd
0.04
-0.02
-28.07%
AU:AMX
Aerometrex Ltd.
0.28
>-0.01
-3.51%
AU:XF1
Xref Ltd
0.14
-0.07
-32.50%
AU:ICE
iCetana Ltd.
0.04
0.03
144.44%

Nanoveu Ltd. Corporate Events

Nanoveu Issues 56.9 Million Unquoted Options Expiring in 2029
Jan 27, 2026

Nanoveu Limited has notified the market of the issue of 56,931,835 unquoted options, each exercisable at $0.15 and expiring on 27 January 2029. The options, which form part of previously announced transactions and are not intended to be quoted on the ASX, expand the company’s pool of unquoted equity securities and may influence future capital structure and potential dilution for existing shareholders if exercised.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Seeks ASX Quotation for 9.25 Million New Shares
Jan 27, 2026

Nanoveu Limited has applied to the ASX for quotation of 9,250,000 new ordinary fully paid shares under code NVU, with an issue date of 27 January 2026. The move increases the company’s quoted share capital, which may enhance liquidity in its stock and provides additional equity that could be used to support future corporate or funding activities, although no further operational or strategic context is provided in the filing.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Seeks ASX Quotation for 83.9 Million New Shares
Jan 27, 2026

Nanoveu Limited has applied for quotation on the ASX of 83,863,637 new fully paid ordinary shares, with an issue date of 27 January 2026. The additional securities, which stem from previously announced transactions, will expand the company’s quoted share base and may enhance liquidity in its stock, potentially supporting future capital access and market visibility for the technology-focused issuer.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Secures $7.38m in Strategic Placement and Option Exercises
Jan 27, 2026

Nanoveu Limited has completed the main tranche of its previously announced strategic placement, raising $7.38 million before costs via the issue of 83.9 million new shares at $0.088 each, accompanied by 41.9 million attaching options, within its existing ASX placement capacity, and has also issued 9.25 million shares following the exercise of unlisted options. The remaining $120,000 component to directors will be finalised subject to shareholder approval, while the company has confirmed that the new securities were issued without a prospectus under the Corporations Act’s disclosure exemptions and that it remains compliant with its continuous disclosure and reporting obligations, bolstering its capital base for ongoing operations and growth initiatives in its semiconductor, 3D content and materials businesses.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Plans Major Share and Option Issue to Raise Capital
Jan 19, 2026

Nanoveu Limited has notified the ASX of a proposed capital raising involving the issue of up to 85,227,274 new fully paid ordinary shares and 57,613,637 options, each with an exercise price of $0.15 and expiring in January 2029. The securities are to be issued by way of a placement or other form of issue, with a proposed issue date of 27 January 2026, signalling a move to strengthen the company’s balance sheet and potentially fund future corporate or operational initiatives, which may affect existing shareholders through dilution while providing additional capital to support Nanoveu’s strategic objectives.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Raises A$7.5m to Fast-Track Edge-AI Chip Commercialisation and Global Expansion
Jan 19, 2026

Nanoveu has secured firm commitments to raise A$7.5 million via an upsized share placement at A$0.088 per share, with free attaching options, from new and existing sophisticated and institutional investors, with directors also participating subject to shareholder approval. The funds will strengthen the balance sheet and accelerate commercialisation of EMASS’s ECS-DoT edge-AI semiconductor platform—supporting the 16nm tape-out process now progressing through TSMC/IMEC workflows, live drone validation of its endurance gains following strong simulation results, as well as broader go-to-market initiatives, international sales expansion, and further development of EyeFly3D and nanocoating technologies, positioning Nanoveu for faster global expansion and deeper engagement with OEMs and system integrators.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Seeks Trading Halt Ahead of Capital Raising Announcement
Jan 15, 2026

Nanoveu Limited has requested an immediate trading halt in its securities on the ASX as it prepares to announce details of a proposed capital raising. The halt will remain in place until either the start of normal trading on 20 January 2026 or the release of the capital-raising announcement, with the company indicating it is not aware of any reasons the halt should not be granted, signalling a potentially significant funding move that may affect its capital structure and investor positioning.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Issues 250,000 Shares on Exercise of Unlisted Options
Jan 14, 2026

Nanoveu Limited has issued 250,000 new ordinary shares following the exercise of unlisted options, modestly expanding its share capital. The company confirmed the shares were issued without a prospectus in reliance on provisions of the Corporations Act, stating it remains compliant with its reporting obligations and that there is no excluded information, signalling a routine capital management move with limited immediate operational impact but incremental funding flexibility for its advanced technology portfolio.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Applies to List 250,000 New Ordinary Shares on ASX
Jan 14, 2026

Nanoveu Limited has applied to the ASX for the quotation of 250,000 new fully paid ordinary shares under the code NVU, with an issue date of 14 January 2026. The securities arise from the exercise or conversion of existing options or other convertible instruments, modestly increasing the company’s quoted share capital and potentially enhancing liquidity for investors.

The most recent analyst rating on (AU:NVU) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Nanoveu Ltd. stock, see the AU:NVU Stock Forecast page.

Nanoveu Seeks ASX Quotation for Over 6 Million New Shares
Dec 24, 2025

Nanoveu Ltd has applied to the ASX for quotation of 6,026,923 new fully paid ordinary shares, to be traded under its existing ticker NVU. The new securities, issued on 24 December 2025 following the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share base and marginally increase its access to equity capital, with implications for existing shareholders’ dilution and market liquidity.

Nanoveu Expands Share Capital Through Exercise of Unlisted Options
Dec 24, 2025

Nanoveu Limited has issued 6,026,923 new ordinary shares following the exercise of unlisted options, expanding its share capital without a separate disclosure document under Australia’s Corporations Act. The company confirmed it is compliant with its continuous disclosure and financial reporting obligations and that there is no excluded information, signalling a routine capital management move that modestly strengthens its equity base while maintaining regulatory transparency for investors.

Nanoveu Limited Announces Investor Webinar on EMASS SoC Advancements
Dec 16, 2025

Nanoveu Limited has announced an investor webinar to discuss the advancements of its subsidiary, EMASS, in ultra-low-power ECS-DoT system-on-chip (SoC) technologies. The webinar will highlight significant milestones such as the tape-out of a new integrated circuit on TSMC’s 16nm FinFET, collaborations with Arrow Electronics and Semtech, and the establishment of a sales network for ECS-DoT solutions. These developments are expected to enhance Nanoveu’s market positioning and offer scalable AI capabilities across various industries.

Nanoveu Advances in Edge AI with 16nm SoC Milestone
Dec 16, 2025

Nanoveu Limited’s subsidiary, Embedded A.I. Systems Pte. Ltd (EMASS), has reached a significant milestone with its 16nm ECS-DoT AIoT system-on-chip (SoC), completing the front-end, synthesis, and physical design stages. This development positions Nanoveu at the forefront of ultra-low-power Edge AI technology, integrating advanced features such as on-chip Bluetooth Low Energy, expanded on-chip memory, and enhanced AI acceleration, which collectively promise to improve energy efficiency and reduce costs for connected devices.

Nanoveu Updates ASX Announcement on Edge AI Collaboration
Dec 9, 2025

Nanoveu Limited announced an amendment to its previous ASX announcement regarding its collaboration with EMASS and Semtech on low-power edge AI. The amendment involved the removal of an incorrectly displayed Semtech logo, with no new material information affecting the release. This collaboration enhances Nanoveu’s portfolio, positioning it as a key player in the rapidly growing 3D content, AI, and edge computing markets.

Nanoveu Limited Announces Director Departure and Lapse of Performance Rights
Nov 30, 2025

Nanoveu Limited has announced that Michael Winlo has ceased to be a director of the company as of December 1, 2025. This change results in the automatic lapse of 2,500,000 Performance Rights previously held by Mr. Winlo, leaving him with no direct or indirect interest in the company’s Performance Rights. This development may impact the company’s governance structure and could have implications for its strategic direction.

Nanoveu Ltd. Appoints New Director with Performance-Based Incentives
Nov 30, 2025

Nanoveu Ltd. has announced the appointment of Mohamed Sabry Aly as a director, effective December 1, 2025. As part of his engagement, the company has agreed to issue him 5,000,000 performance rights, contingent upon the company achieving certain stock price milestones. This appointment and the associated performance rights reflect Nanoveu’s strategic focus on strengthening its leadership team to drive future growth and achieve market objectives.

Nanoveu Limited Strengthens Leadership with New Board Appointments
Nov 30, 2025

Nanoveu Limited has announced the appointment of Professor Mohamed Sabry Aly and Mr. Raymond Chen as directors, effective December 1, 2025. Professor Aly, a non-independent non-executive director, brings significant technical expertise from his work in embedded AI and semiconductor technologies, while Mr. Chen, the current CFO, adds extensive financial and corporate experience. These appointments are part of Nanoveu’s strategic growth initiatives as the company seeks to enhance its leadership and pursue collaborations with global corporations. The company is also searching for additional strategic advisors to support its growth in edge-AI, IoT, drone, and semiconductor technologies.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 09, 2026